Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study
Ter Braake JG, Fleetwood KJ, Vos RC, et al.
Diabetologia. Pub. online 26 Feb 2024.
Leggi
Breaking news
Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study
Liarakos AL, Hasan N, Crabtree TSJ, et al.
Diabetes Research and Clinical Practice. Pub. online 27 Feb 2024.
Leggi
Elevated ITGA1 levels in type 2 diabetes: implications for cardiac function impairment
Su M, Hou Y, Cai S, et al.
Diabetologia. Pub. online 27 Feb 2024.
Leggi
Individualizing care for older adults with diabetes amid the revolution in pharmacotherapy
Huang ES
JAMA Intern Med. Pub. online 26 Feb 2024.
Leggi
FDA Safety Communication – Do not use smartwatches or smart rings to measure blood glucose levels
21/02/2024
Leggi
Hyperlipidaemia in diabetes: are there particular considerations for next generation therapies?
Béliard S, Mourre F, Valéro R
Diabetologia. Pub. online 20 Feb 2024.
Leggi
Non-pharmacological interventions to improve cardiovascular risk factors in people with diabetic foot disease: A systematic review and meta-analysis
Highton P, Almaqhawi A, Oroko M, et al.
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Effect of low dose semaglutide in people with type 1 diabetes and excess weight
Grassi BA, Onetto MT, Sánchez C, Tapia N, Mena F
Diabetes Research and Clinical Practice. Pub. online 24 Feb 2024.
Leggi
Safety, tolerability and immunogenicity of PRV 101, a multivalent vaccine targeting coxsackie B viruses (CVBs) associated with type 1 diabetes: a double blind randomised placebo controlled Phase I trial
Hyöty H, Kääriäinen S, Laiho JE, t al.
Diabetologia. Pub. online 19 Feb 2024.
Leggi
Phenotype based targeted treatment of SGLT2 inhibitors and GLP 1 receptor agonists in type 2 diabetes
Cardoso P, Young KG, Nair ATN, et al.
Diabetologia. Pub. online 22 Feb 2024.
Leggi